
EFA Technologies develops and engineers accessible, affordable, simple to use, and portable medical technology. Their flagship product, RevDx™, is a complete AI blood count device that provides instant results within minutes, eliminating the need for laboratory or clinic visits. The portable 2.5kg device is designed for ease of use and can be taken anywhere to perform blood tests on the spot. RevDx™ is engineered as a platform technology, enabling multiple diagnostic applications over time and utilizing an AI-based microscope. The company's vision is to make quality healthcare accessible to everyone, bridging gaps in medical access, particularly in remote locations. EFA collaborates with healthcare providers, NGOs, governments, and local communities to achieve sustainable pathways to better health. The company has secured US$6.5M in funding and has a business model that includes developing a marketplace for health apps and diagnostic needs, supporting telemedicine applications.

EFA Technologies develops and engineers accessible, affordable, simple to use, and portable medical technology. Their flagship product, RevDx™, is a complete AI blood count device that provides instant results within minutes, eliminating the need for laboratory or clinic visits. The portable 2.5kg device is designed for ease of use and can be taken anywhere to perform blood tests on the spot. RevDx™ is engineered as a platform technology, enabling multiple diagnostic applications over time and utilizing an AI-based microscope. The company's vision is to make quality healthcare accessible to everyone, bridging gaps in medical access, particularly in remote locations. EFA collaborates with healthcare providers, NGOs, governments, and local communities to achieve sustainable pathways to better health. The company has secured US$6.5M in funding and has a business model that includes developing a marketplace for health apps and diagnostic needs, supporting telemedicine applications.